Trial
NCT02483195
The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
—
Condition
Female Androgenetic Alopecia
Intervention
5% Minoxidil
Why stopped
PI indicating she was withdrawing her study submission due to lack of funding as of 6/20/2016
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-02